France hits target of 20 million first Covid-19 vaccinations, says PM

France has administered the first doses of Covid-19 vaccines to 20 million people, French Prime Minister Jean Castex said

vaccination, coronavirus, covid-19, vaccine
IANS Paris
2 min read Last Updated : May 16 2021 | 7:33 AM IST

France has administered the first doses of Covid-19 vaccines to 20 million people, reaching its target days ahead of the reopening of catering businesses and cultural venues, French Prime Minister Jean Castex said on Saturday.

Castex announced on Twitter the hitting of the 20-million mark, a number that represents some 30 per cent of the population, the Xinhua news agency reported.

"This is a very important moment for the whole country because it supports our prospects for ending the crisis, reinforced by the evolution of the epidemic data, which is regressing everywhere in France," Castex said earlier in the day during a visit to the mass vaccination site at the Porte de Versailles conference center in Paris.

"The next target is 30 million first doses. It is within our reach," he added.

Covid-19 hospital admissions continued to decline in France on Saturday. In the past 24 hours, the number of hospitalized patients went down by 456 to 22,950 patients, continuing a negative trend for the second week in a row.

The number of intensive care patients, a key gauge to evaluate the health system's ability to cope with the epidemic, fell by 81 to 4,271.

Since the epidemic outbreak, France has confirmed 5.86 million cases and 107,535 deaths. The two indicators grew by 15,685 and 112 in one day respectively.

From May 19, non-essential shops will reopen in France. Restaurants and cafes will be allowed to take in half of their capacity on terraces with a maximum of six people per table. Museums, theatres, cinemas and sport facilities will also reopen, with a limit of 800 people indoors and 1,000 outdoors.

--IANS

int/rs

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus Vaccine

First Published: May 16 2021 | 7:27 AM IST

Next Story